| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | $2.3B | $1.3B | $2.6B | $8.3B | $11.1B |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $-0.1B | $0.0B | $-0.0B | $0.0B | $0.3B | $0.1B |
| EPS (Basic) | $-0.05 | $0.21 | $-0.12 | $0.39 | $2.36 | $1.21 |
| EPS (Diluted) | $-0.05 | $0.21 | $-0.15 | $0.28 | $2.32 | $1.09 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $60.7B | $24.5B | $19.2B | $20.1B | $32.8B | $37.5B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $2.7B | $1.3B | $1.1B | $0.7B | $2.1B | $2.0B |
| Total Liabilities | $37.8B | $15.5B | $10.9B | $11.6B | $23.0B | $29.7B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-3.9B | $-2.6B | $0.1B | $10.8B | $7.7B | $-1.7B |
| Investing Cash Flow | $-2.5B | $-0.5B | $0.9B | $0.6B | $-0.7B | $0.5B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $8.1B | $3.3B | $-0.6B | $-12.8B | $-6.9B | $1.8B |